This 2017 review explores targeting the Warburg effect—a metabolic hallmark where cancer cells favor glycolysis over oxidative phosphorylation, leading to an acidic tumor microenvironment. The authors propose a therapeutic strategy combining metabolic modulators (e.g., dichloroacetate, metformin) and pH regulators to disrupt cancer cell metabolism and restore pH balance. Preclinical studies